Search Results 1001-1010 of 19744 for Hepatitis+C

1. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

   Detectable viral infections (e.g. known HIV, known active hepatitis B or C). Participating Mayo Clinic locations. Study statuses change often. Please contact ...

2. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

   Known active hepatitis B or C infection. 11. Invasive fungal infection. 12. Uncontrolled (as per clinical judgment) pleural/pericardial effusions or ascites ...

3. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis - Mayo Clinic

   Hepatitis B, C or HIV positive. Pregnant or breast-feeding. Active infection. Kidney transplant. Anemia with Hgb < 8.0 g/dL. Thrombocytopenia with platelet ...

4. Losartan for Outpatients on COVID-19 - Clinical Trials

   History of hepatitis B or C;; Other liver disease that in the opinion of the investigator, would affect losartan clearance;; Documented AST or ALT > 3 times ...

5. Ethinyl estradiol and ethynodiol diacetate (oral route) - Mayo Clinic

   Do not use this medicine together with medicine to treat hepatitis C virus infection, including ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( ...

6. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... Hepatitis B or Hepatitis C; Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed four (4) weeks prior to first dose ...

7. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

   Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on ...

8. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

   Patients must not have a known history of HIV, hepatitis B, or hepatitis C infection that is untreated and/or with a detectable viral load. Patients must ...

9. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... hepatitis B virus surface antigen (HBV sAg+), active hepatitis C (if Ab+ then PCR+) indicating acute or chronic infection; Uncontrolled intercurrent illness ...

10. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

    Autoimmune hepatitis (AIH) indicative of PBC with overlap syndrome. ... Moderate to severe interface hepatitis on histology. ... (c) platelet count <140x109/L with ...